Date | Source | Headline | |
---|---|---|---|
10th Mar 2010 | 1:21 pm | RNS | EPT Disclosure |
10th Mar 2010 | 11:52 am | RNS | EPT Disclosure |
10th Mar 2010 | 7:00 am | RNS | Final Results |
9th Mar 2010 | 7:00 am | RNS | Research Update |
8th Mar 2010 | 5:34 pm | RNS | Holding(s) in Company |
23rd Feb 2010 | 7:00 am | RNS | Research Update |
19th Feb 2010 | 7:00 am | RNS | Re Agreement |
16th Feb 2010 | 4:40 pm | RNS | Second Price Monitoring Extn |
16th Feb 2010 | 4:35 pm | RNS | Price Monitoring Extension |
11th Feb 2010 | 11:37 am | RNS | Director/PDMR Shareholding |
5th Feb 2010 | 4:35 pm | RNS | Price Monitoring Extension |
29th Jan 2010 | 3:23 pm | RNS | Total Voting Rights |
28th Jan 2010 | 11:05 am | RNS | Notice of Results |
28th Jan 2010 | 7:02 am | RNS | Research Update |
28th Jan 2010 | 7:00 am | RNS | Research Update |
20th Jan 2010 | 3:51 pm | RNS | Employee Benefit Trust |
5th Jan 2010 | 7:00 am | RNS | Ark files for re-examination of Cerepro |
22nd Dec 2009 | 4:41 pm | RNS | Second Price Monitoring Extn |
22nd Dec 2009 | 4:35 pm | RNS | Price Monitoring Extension |
18th Dec 2009 | 11:56 am | RNS | EMEA recommendation on Cerepro |
15th Dec 2009 | 2:29 pm | RNS | Holding(s) in Company |
3rd Dec 2009 | 2:41 pm | RNS | Blocklisting Interim Review |
3rd Dec 2009 | 2:35 pm | RNS | Holding(s) in Company |
24th Nov 2009 | 4:04 pm | RNS | Holding(s) in Company |
11th Nov 2009 | 7:00 am | RNS | Interim Management Statement |
14th Oct 2009 | 7:00 am | RNS | Research Update |
2nd Oct 2009 | 11:04 am | RNS | Holding(s) in Company |
30th Sep 2009 | 10:51 am | RNS | Holding(s) in Company |
29th Sep 2009 | 4:32 pm | RNS | Holding(s) in Company |
4th Sep 2009 | 7:00 am | RNS | Research Update |
1st Sep 2009 | 12:08 pm | RNS | Director/PDMR Shareholding |
26th Aug 2009 | 7:00 am | RNS | Research Update |
26th Aug 2009 | 7:00 am | RNS | Half Yearly Report |
13th Jul 2009 | 7:00 am | RNS | Ark launches Kerraglove woundcare device |
1st Jul 2009 | 7:00 am | RNS | Re Agreement |
26th Jun 2009 | 2:15 pm | RNS | Holding(s) in Company |
24th Jun 2009 | 7:00 am | RNS | Manufacturing Update |
17th Jun 2009 | 7:00 am | RNS | Re Agreement |
3rd Jun 2009 | 11:47 am | RNS | Blocklisting Interim Review |
21st May 2009 | 7:00 am | RNS | Trinam Phase III Study Enrols First Patient |
18th May 2009 | 7:00 am | RNS | Interim Management Statement |
15th May 2009 | 7:00 am | RNS | Cerepro Named Patient Supply approved in Finland |
13th May 2009 | 4:41 pm | RNS | Second Price Monitoring Extn |
13th May 2009 | 4:35 pm | RNS | Price Monitoring Extension |
12th May 2009 | 7:00 am | RNS | Director/PDMR Shareholding |
6th May 2009 | 4:40 pm | RNS | Second Price Monitoring Extn |
6th May 2009 | 4:35 pm | RNS | Price Monitoring Extension |
5th May 2009 | 7:00 am | RNS | Trinam(R) Awarded Fast Track Status by FDA |
30th Apr 2009 | 4:01 pm | RNS | Total Voting Rights |
30th Apr 2009 | 12:00 pm | RNS | Prestigious European Award |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.